Literature DB >> 11414550

What is generalized anxiety disorder?

K Rickels1, M A Rynn.   

Abstract

Generalized, persistent, and free-floating anxiety was first described by Freud in 1894, although the diagnostic term generalized anxiety disorder (GAD) was not included in classification systems until 1980 (Diagnostic and Statistical Manual for Mental Disorders, Third Edition [DSM-III]). Initially considered a residual category to be used when no other diagnosis could be made, it is now widely accepted that GAD represents a distinct diagnostic category. Since 1980, revisions to the diagnostic criteria for GAD in the DSM-III-R and DSM-IV classifications have markedly redefined this disorder, increasing the duration criterion to 6 months and increasing the emphasis on worry and psychic symptoms. This article reviews the development of the diagnostic criteria for defining GAD from Freud to DSM-IV and compares the DSM-IV criteria with the criteria set forth in the tenth revision of the International Classification of Diseases. The impact of the changes in diagnostic criteria on research into GAD, and on diagnosis, differential diagnosis, and treatment of GAD, will be discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11414550

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

Review 1.  Animal models of anxiety disorders.

Authors:  Joachim D K Uys; Dan J Stein; Willie M U Daniels; Brian H Harvey
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication.

Authors:  Ayelet Meron Ruscio; Wai Tat Chiu; Peter Roy-Byrne; Paul E Stang; Dan J Stein; Hans-Ulrich Wittchen; Ronald C Kessler
Journal:  J Anxiety Disord       Date:  2006-11-21

3.  Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication.

Authors:  Ayelet Meron Ruscio; Michael Lane; Peter Roy-Byrne; Paul E Stang; Dan J Stein; Hans-Ulrich Wittchen; Ronald C Kessler
Journal:  Psychol Med       Date:  2005-12       Impact factor: 7.723

4.  The generalized anxiety spectrum: prevalence, onset, course and outcome.

Authors:  Jules Angst; Alex Gamma; David S Baldwin; Vladeta Ajdacic-Gross; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-24       Impact factor: 5.270

Review 5.  Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

Authors:  Keming Gao; David V Sheehan; Joseph R Calabrese
Journal:  Expert Rev Neurother       Date:  2009-08       Impact factor: 4.618

6.  Chronic insomnia as a risk factor for developing anxiety and depression.

Authors:  Dag Neckelmann; Arnstein Mykletun; Alv A Dahl
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

7.  Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians.

Authors:  Hannu Koponen; Christer Allgulander; Janelle Erickson; Eduardo Dunayevich; Yili Pritchett; Michael J Detke; Susan G Ball; James M Russell
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 8.  Culture and the anxiety disorders: recommendations for DSM-V.

Authors:  Roberto Lewis-Fernández; Devon E Hinton; Amaro J Laria; Elissa H Patterson; Stefan G Hofmann; Michelle G Craske; Dan J Stein; Anu Asnaani; Betty Liao
Journal:  Depress Anxiety       Date:  2010-02       Impact factor: 6.505

9.  Management of generalised anxiety disorder in adults: summary of NICE guidance.

Authors:  Tim Kendall; John Cape; Melissa Chan; Clare Taylor
Journal:  BMJ       Date:  2011-01-26

10.  Are Psychiatric Diagnoses an Obstacle for Research and Practice? Reliability, Validity and the Problem of Psychiatric Diagnoses. The Case of GAD.

Authors:  Carlo Faravelli; Giovanni Castellini; Monica Landi; Andrea Brugnera
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.